For the study, the researchers gave the study participants an experimental anti-amyloid drug. They found that 22 participants ...
The platform features Healthgrades, a tool intended to connect Alzheimer's patients to experienced local clinicians.
The European Union's drugs regulator on Friday rejected Eli Lilly's Alzheimer's drug, saying the risk of serious brain ...
Certain widely used drug combinations may either slow down or worsen the progression of Alzheimer's disease, but their ...
For some people with a high risk of Alzheimer's who received a drug called gantenerumab for eight years, their risk of ...
There’s currently no cure for dementia. Although some recently developed drugs show promise in slowing the progress of the ...
The latest drugs for Alzheimer's disease may add years of independence to the lives of patients, but possibly only for some.
An experimental treatment appears to postpone Alzheimer's symptoms in some people genetically destined to get the disease at ...
Alzheimer’s disease doesn’t have a cure, meaning no treatment can reverse the damage that’s already occurred in the brain. But that doesn’t mean life has to come to a screeching halt.
Research shows experimental anti-amyloid drug reduced cognitive symptom risk by 50% in people with rare genetic mutations ...
A groundbreaking study by researchers at the Queensland Brain Institute reveals that low-intensity ultrasound therapy can ...
A clinical trial involving individuals genetically predisposed to develop early-onset Alzheimer’s disease suggests that ...